Mirae Asset Global Investments’s Pacira BioSciences PCRX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $42.8K | Buy |
1,789
+241
| +16% | +$5.76K | ﹤0.01% | 1284 |
|
2025
Q1 | $38.6K | Buy |
1,548
+9
| +0.6% | +$224 | ﹤0.01% | 1289 |
|
2024
Q4 | $30.2K | Sell |
1,539
-129
| -8% | -$2.54K | ﹤0.01% | 1358 |
|
2024
Q3 | $24.3K | Buy |
1,668
+278
| +20% | +$4.04K | ﹤0.01% | 1407 |
|
2024
Q2 | $38.8K | Sell |
1,390
-19,687
| -93% | -$549K | ﹤0.01% | 1293 |
|
2024
Q1 | $826K | Sell |
21,077
-896
| -4% | -$35.1K | ﹤0.01% | 1642 |
|
2023
Q4 | $741K | Buy |
21,973
+1,186
| +6% | +$40K | ﹤0.01% | 1769 |
|
2023
Q3 | $638K | Buy |
20,787
+50
| +0.2% | +$1.53K | ﹤0.01% | 1764 |
|
2023
Q2 | $831K | Sell |
20,737
-93
| -0.4% | -$3.73K | ﹤0.01% | 1677 |
|
2023
Q1 | $850K | Sell |
20,830
-28
| -0.1% | -$1.14K | ﹤0.01% | 1629 |
|
2022
Q4 | $805K | Buy |
20,858
+878
| +4% | +$33.9K | ﹤0.01% | 1619 |
|
2022
Q3 | $1.06M | Buy |
19,980
+5,765
| +41% | +$307K | ﹤0.01% | 1452 |
|
2022
Q2 | $829K | Buy |
+14,215
| New | +$829K | ﹤0.01% | 1505 |
|
2018
Q1 | – | Sell |
-37,895
| Closed | -$1.73M | – | 756 |
|
2017
Q4 | $1.73M | Buy |
+37,895
| New | +$1.73M | 0.02% | 379 |
|
2015
Q3 | – | Sell |
-21,788
| Closed | -$1.54M | – | 472 |
|
2015
Q2 | $1.54M | Buy |
+21,788
| New | +$1.54M | 0.05% | 247 |
|